Biomerica Inc.
BMRA | NASDAQ
$2.60
+$0.09 (+3.59%)
At close: Sep 21, 2026, 4:00 PM ET
$2.54
-$0.06 (-2.31%)
After-hours:
Sep 21, 2026, 4:10 PM ET
Fiscal Year Period Ending | FY 2026 May 30, 2026 | FY 2025 May 30, 2025 | FY 2024 May 30, 2024 | FY 2023 May 30, 2023 | FY 2022 May 30, 2022 | FY 2021 May 30, 2021 |
|---|---|---|---|---|---|---|
Revenue | 4.45M | 5.31M | 5.42M | 5.34M | 18.87M | 7.2M |
Cost of Revenue | 4.09M | 4.81M | 4.8M | 4.89M | 15.89M | 6.83M |
Gross Profit | 362K | 498K | 611K | 446K | 2.98M | 366.29K |
Operating Income | -5.32M | -5.14M | -6.37M | -7.22M | -4.53M | -7.5M |
Interest Income | 1.23M | 165K | 431K | 133K | 27K | 66.86K |
Pretax Income | -3.75M | -4.97M | -5.94M | -7.09M | -4.51M | -7.43M |
Net Income | -3.78M | -4.97M | -5.98M | -7.14M | -4.53M | -7.45M |
Selling & General & Admin | 4.89M | 4.61M | 5.49M | 6.09M | 5.7M | 5.67M |
Research & Development | 788K | 1.02M | 1.49M | 1.58M | 1.81M | 2.19M |
Other Expenses | n/a | n/a | n/a | 1K | n/a | n/a |
Operating Expenses | 5.68M | 5.64M | 6.98M | 7.67M | 7.51M | 7.87M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 367 |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 9.77M | 10.45M | 11.78M | 12.56M | 23.41M | 14.7M |
Income Tax Expense | 23K | 1K | 42K | 51K | 23.72K | 13.06K |
Shares Outstanding (Basic) | 2.91M | 2.3M | 16.82M | 14.15M | 12.67M | 11.93M |
Shares Outstanding (Diluted) | 2.91M | 2.3M | 16.82M | 14.15M | 12.67M | 11.93M |
EPS (Basic) | -1.30 | -2.16 | -0.36 | -0.50 | -0.36 | -0.54 |
EPS (Diluted) | -1.30 | -2.16 | -0.36 | -0.50 | -0.36 | -0.54 |
EBITDA | -4.9M | -4.57M | -5.56M | -6.74M | -3.94M | -7.06M |
EBIT | -5.32M | -4.97M | -5.94M | -7.09M | -4.53M | -7.43M |
Depreciation & Amortization | 421K | 400K | 374K | 351K | 594.82K | 375.86K |
Add to Watchlist
Select watchlists to add or remove BMRA